But the framework has perhaps created as much confusion as clarity. Broadly, the FDA said it will limit approval of Covid-19 ...

FDA Commissioner Dr. Marty Makary and vaccine chief Dr. Vinay Prasad set stricter approval standards for booster shots ...

A lot of 2024 retrospectives have been based on vibes. Now we have some really good data. Here’s what it says.

We want to know more about what these products are doing,” said Dr. Vinay Prasad during a recent FDA livestreamed ...

The U.S. Food and Drug Administration has announced a significant shift in its COVID-19 vaccination policy, limiting routine approval of annual booster shots to individuals aged 65 and older, as well ...

China continues to be a source of innovation as Pfizer strikes biggest pact yet; HHS provides more info on Trump’s Most Favored Nation executive order; FDA Commissioner Marty Makary and CBER director ...

Federal regulators will only approve COVID-19 boosters for seniors and high-risk groups. Officials want more data before ...

The US Food and Drug Administration (FDA) is set to restrict Covid-19 booster doses to older adults and those at risk of ...

The Trump administration said Tuesday it will limit approval for seasonal COVID-19 shots to seniors and others at high risk ...

US regulators will no longer approve Covid booster shots for healthy adults and children without new studies, adding a costly ...

The FDA also gave full approval to the Novavax COVID vaccine (Nuvaxovid) using this approach, approving it for those ages 65 ...